Trial intelligence / Profile preview

Norepinephrine vs Vasopressin in Cardiac Surgery Patients

NCT04501861Phase 3Completed

Sponsor
Cleveland Clinic
Start
Nov 2020
Primary completion
Aug 2023
Modality
Peptides
Countries
1
01

Overview

A Phase 3 trial of vasopressin, norepinephrine in hypotension, sponsored by Cleveland Clinic. Started Nov 2020; status: completed.

02

Drugs

vasopressinnorepinephrine
03

Conditions

hypotension

Beyond the preview

Go deeper on NCT04501861.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04501861.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call